KLAS: Providers Value Clinical Evidence from CDS Vendors, but Obstacles Remain | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

KLAS: Providers Value Clinical Evidence from CDS Vendors, but Obstacles Remain

January 22, 2013
by Rajiv Leventhal
| Reprints

Providers are looking to third-party vendors to keep pace with clinical evidence, but many struggle to embed that content into their electronic medical record (EMR) and clinical workflow, according to a new report from Orem, Ut.-based KLAS Research. Order sets, care plans and drug databases have the potential to impact care for every patient and are the bedrocks of clinical decision support (CDS) for many organizations.

"The focus of this report is what vendors are doing to address the challenges that providers have to stay current with a growing body of clinical evidence and then using it to affect decisions at the point of care," says report author Coray Tate. "Order sets, care plans and drug databases clearly play important roles in what healthcare reform is trying to accomplish. Realizing their benefit requires coordinated efforts from CDS and EMR vendors and, most importantly, determination on the part of providers."

The study looks at how the three separate types of CDS tools interact with providers' EMRs. It compares third-party vendors' performance as well as the contributions of the different EMR solutions. Care plan and order set vendors include Elsevier, Wolters Kluwer, and Zynx Health. Drug database vendors include Cerner Multum, First Databank, and Wolters Kluwer Medi-Span.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).